Stock ACUC ACUCORT AB
Add to a list
To use this feature you must be a member
Log inSign up

AcuCort AB Stock

Equities

ACUC

SE0009695927

Drug Retailers

End-of-day quote NORDIC GROWTH MARKET
Other stock markets
 06:00:00 2024-04-28 pm EDT 		5-day change 1st Jan Change
0.54 SEK -3.57% Intraday chart for AcuCort AB 0.00% +30.12%
Apr. 26 AcuCort AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 16 AcuCort AB Provides Update on Phase IV Study ZEQ001 CI

Financials

Sales 2022 5.02 55.15 Sales 2023 6.59 72.37 Capitalization 12.98M 143M
Net income 2022 -14M -154M Net income 2023 -13M -143M EV / Sales 2022 8,567,999 x
Net cash position 2022 17.18M 189M Net cash position 2023 19.24M 211M EV / Sales 2023 -949,961 x
P/E ratio 2022
-4.1 x
P/E ratio 2023
-0.94 x
Employees 3
Yield 2022 *
-
Yield 2023
-
Free-Float 81.96%
More Fundamentals * Assessed data

Chart AcuCort AB

Dynamic Chart

Latest news about AcuCort AB

AcuCort AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
AcuCort AB Provides Update on Phase IV Study ZEQ001 CI
AcuCort AB Announces Update on FDA Application Ahead of Launch in the USA CI
Acucort Lands First Zeqmelit Order from Unimedic Pharma MT
AcuCort AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
AcuCort Initiates Study for Acute Allergy Medication Zeqmelit MT
AcuCort AB Announces First Patient Using Zeqmelit in Study Ahead of Market Launch CI
AcuCort’s Oral Film Gains 10-year Trademark Protection in Switzerland MT
AcuCort Secures Trademark Protection for Zeqmelit in India MT
AcuCort AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
AcuCort AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Acucort AB Signs Partnership Agreement for the Four Major Nordic Countries with Unimedic Pharma CI
AcuCort Receives Ethics Approval for Study with Zeqmelit® CI
Acucort Receives Patent for Oral Film in Brazil CI
AcuCort AB Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
More news

Press releases AcuCort AB

AcuCort publishes the annual report for 2023 AQ
Update on Phase IV Study: 40 of 50 Patients Recruited AQ
AcuCort's study to be published in an international scientific journal AQ
Update on Phase 4 Study: 25 Patients Recruited AQ
Insider trading in subscription option TO1 - CEO Jonas Jönmark increases his stake in AcuCort AB AQ
More press releases

Quotes and Performance

1 day-3.57%
Current month-10.00%
1 month-10.00%
3 months+52.54%
6 months+26.17%
Current year+30.12%
More quotes

Highs and lows

1 week
0.48
Extreme 0.48
0.61
1 month
0.44
Extreme 0.44
0.68
Current year
0.34
Extreme 0.342
0.70
1 year
0.33
Extreme 0.327
1.60
3 years
0.33
Extreme 0.327
5.42
5 years
0.33
Extreme 0.327
7.90
10 years
0.33
Extreme 0.327
9.50
More quotes

Managers and Directors - AcuCort AB

Managers TitleAgeSince
Jonas Jonas Jönmark CEO
 Chief Executive Officer 53 20-08-08
Members of the board TitleAgeSince
Anna Maria Albertina Eriksrud BRD
 Director/Board Member 66 17-02-07
Göran Tornling BRD
 Director/Board Member 77 20-12-31
Monica Kristina Wallter BRD
 Director/Board Member 68 20-12-31
More insiders

Quotes

Date Price Change Volume
24-04-29 0.54 -3.57% 845,507
24-04-26 0.56 -6.67% 1,644,357
24-04-25 0.6 +5.26% 1,561,091
24-04-24 0.57 +3.64% 1,149,640
24-04-23 0.55 +1.85% 1,184,193

End-of-day quote NORDIC GROWTH MARKET, April 28, 2024

More quotes

Company Profile

AcuCort AB is a Sweden-based pharmaceutical company. The company develops oral films ISICORT, which involve chemical substance glucocorticoid dexamethasone that is used for the treatment of acute allergic reactions, as well as for nausea and vomiting during chemotherapy treatments. AcuCort AB operates mostly in Nordic countries.
Sector
Drug Retailers
Calendar
2024-08-22 - Q2 2024 Earnings Release
More about the company

Income Statement Evolution

More financial data

Sector Other Drug Retailers

1st Jan change Capi.
ACUCORT AB Stock AcuCort AB
+30.12% 5.89M
WALGREENS BOOTS ALLIANCE, INC. Stock Walgreens Boots Alliance, Inc.
-32.21% 15.55B
JD HEALTH INTERNATIONAL INC. Stock JD Health International Inc.
-30.56% 11.21B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Stock Alibaba Health Information Technology Limited
-30.19% 6.23B
YIFENG PHARMACY CHAIN CO., LTD. Stock Yifeng Pharmacy Chain Co., Ltd.
+9.74% 6B
MATSUKIYOCOCOKARA & CO. Stock MatsukiyoCocokara & Co.
-10.01% 5.89B
NAHDI MEDICAL COMPANY Stock Nahdi Medical Company
+0.88% 4.72B
CORPORATIVO FRAGUA, S.A.B. DE C.V. Stock Corporativo Fragua, S.A.B. de C.V.
+53.60% 4.32B
CLICKS GROUP LIMITED Stock Clicks Group Limited
-9.42% 3.77B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD. Stock DaShenLin Pharmaceutical Group Co., Ltd.
-12.53% 3.4B
Other Drug Retailers
  1. Stock Market
  2. Equities
  3. ACUC Stock